
    
      A double-blinded, randomized, comparative, crossover pharmacokinetics study of Rinsulin® NPH,
      suspension for subcutaneous administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin®
      NPH, suspension for subcutaneous administration, 100 IU/ml (Lilly France, France) using
      method of euglycemic hyperinsulinemic clamp on healthy volunteers
    
  